|

Neurocognitive Trajectories After BCMA CAR-T

RECRUITINGSponsored by Wake Forest University Health Sciences
Actively Recruiting
SponsorWake Forest University Health Sciences
Started2026-11
Est. completion2029-11
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

The purpose of this research study is to evaluate cognitive changes over time in participants with relapsed or refractory multiple myeloma who have received chimeric antigen receptor T-cell therapy (CAR-T).

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Ability to understand and willingness to sign an IRB-approved informed consent
2. Ability to retain independent decision-making capacity as per the enrolling investigator
3. Age ≥ 18 years of age at the time of consent
4. Scheduled to receive BCMA CAR-T therapy for RRMM as confirmed by the treating clinician
5. Ability to read and understand the English language
6. ECOG 0-2
7. If actively taking benzodiazepine, must be able to hold for 3 hours prior to study assessments as per treating clinician
8. Reliable access to internet access; a tablet, laptop and/or desktop computer with a camera; or willingness to come into the clinic to conduct study procedures as outlined in the Study Calendar- as per participant self-report
9. Ability to complete required assessments, as determined by the treating clinician

Exclusion Criteria:

1. Active central nervous system (CNS) disease
2. Known neurodegenerative disease or major neurocognitive disorder
3. Stroke and/or traumatic brain injury (TBI) within 12 months
4. Concurrent investigational neuroactive drugs

Conditions4

CART TherapyCancerMultiple Myeloma (MM)Refractory Multiple Myeloma (RRMM)

Locations1 site

Atrium Health Levine Cancer
Courtney Schepel980-292-0817courtney.schepel@advocatehealth.org

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.